Medicine and Dentistry
Cystectomy
96%
Bladder Cancer
66%
Non Muscle Invasive Bladder Cancer
50%
Prostate Cancer
29%
Biopsy Technique
29%
Computer Assisted Tomography
19%
Intravesical Drug Administration
19%
Nutrition Supplement
17%
Ureteroscopy
17%
Surgery
17%
Muscle Invasive Bladder Cancer
17%
Urologist
17%
Diagnosis
14%
Watchful Waiting
14%
Mycobacterium Bovis BCG
14%
Needle Biopsy
14%
Multivariate Analysis
14%
Elderly Patient
14%
Controlled Clinical Trial
14%
Neoplasm
14%
Activities of Daily Living
14%
Bladder
14%
Adverse Event
14%
Side Effect
14%
Breathing
14%
Androgen
14%
Kidney Tumour
14%
Serositis
14%
Antithrombotic
14%
Ureter Stone
14%
Antiplatelet Drug
14%
Magnetic Resonance Imaging
14%
Lifestyle Intervention
14%
Glycemic
14%
Oncolytic Virotherapy
14%
Immunotherapy
14%
Reoviridae
14%
Calcium Oxalate Stone
14%
Peyronie's Disease
14%
Diabetes Mellitus
14%
Fine-Needle Aspiration
14%
Urology
12%
Metastatic Carcinoma
12%
Whewellite
11%
Prostate Specific Antigen Test
11%
Diagnostic Testing
11%
Th1 Th2 Balance
10%
Arginine
10%
Overall Survival
9%
Low Carbohydrate Diet
8%
Keyphrases
Radical Cystectomy
100%
Bladder Cancer
58%
Non-muscle Invasive Bladder Cancer (NMIBC)
55%
Intravesical
19%
Ureteroscopy
17%
Muscle-invasive Bladder Cancer
17%
Postoperative Day
16%
Anticoagulation Agents
14%
Watchful Waiting
14%
Residency Training
14%
Active Surveillance
14%
Multivariate Analysis
14%
Molecular Subtypes
14%
Adverse Events
14%
Patient Assessment
14%
United States
14%
Patient Variables
14%
Immunonutrition
14%
Intravesical BCG
14%
Ureteral Stone
14%
S-type
14%
Bladder Preservation
14%
Prostate Cancer
14%
Training Level
14%
Surgical Variables
14%
Intraoperative Management
14%
Mouse Tumor Model
14%
Wasted Time
14%
Inflammatory Response
14%
Intravesical Chemotherapy
14%
Core Needle Biopsy
14%
Concordance Rate
14%
Mitochondrial DNA
14%
Oncolytic Virotherapy
14%
Antiplatelet Agents
14%
Anterior-posterior
14%
Diagnostic Ratios
14%
Randomized Controlled Clinical Trial
14%
Intravesical Therapy
14%
Time Management
14%
Elderly Patients
14%
Funding Sources
14%
Lifestyle Intervention
14%
Stone Composition
14%
Glycemic Efficacy
14%
Calcium Oxalate
14%
Calcium Oxalate Stones
14%
Peyronie's Disease
14%
Nephrometry Score
14%
Size Limit
14%